How a Ghostwritten Glyphosate Study Stayed in Circulation for 25 Years
When a scientific paper is retracted, it is usually treated as a correction to the record. The issue is acknowledged, the paper is withdrawn, and the system moves forward. But the recent retraction of Williams, Kroes, and Munro (2000) doesn’t follow that familiar pattern.
This was not a marginal study quietly removed after limited impact. It was widely cited, relied upon in regulatory contexts, and described by the journal itself as a “hallmark” paper in the discussion around glyphosate safety.
What makes this case worth examining is not just that the paper was eventually retracted, but how long it remained in place after serious concerns about its origins were already publicly known.
Glyphosate Study Timeline: What Happened and When
Looking at the sequence of events helps explain why this matters.
- 2000 — The Williams et al. paper is published and becomes a widely cited reference on glyphosate safety.
- 2017 — The Monsanto Papers are released, revealing evidence of ghostwriting in glyphosate-related research, including this paper.
- 2017–2025 — The paper remains in circulation, continues to be cited, and is used in scientific and regulatory contexts.
- 2025 — A formal request for retraction is finally made.
- Shortly after — The journal retracts the paper.
What stands out is that the retraction did not rely on new evidence. The concerns cited—undisclosed authorship, reliance on unpublished company data, and lack of transparency—had already been documented years earlier.
Why the Glyphosate Study Was Retracted
The reasons given for the retraction go to the core of scientific integrity. According to the journal, the paper involved:
- Undisclosed corporate authorship (ghostwriting)
- Reliance on unpublished industry data
- Failure to disclose financial relationships
- Omission of relevant scientific studies
These are not minor technical issues or formatting oversights. They affect how the research should be interpreted and whether it can be considered independent.
The paper’s influence makes this particularly significant. It had become a central reference point in the glyphosate safety debate, meaning its conclusions were not just read—they were reused, repeated, and embedded into broader discussions.
How the Glyphosate Study Stayed in Circulation for Years
There is no single explanation, but several factors help explain how this paper remained active in the scientific literature for so long after concerns were raised.
The Journal Behind the Glyphosate Study
The study was published in Regulatory Toxicology and Pharmacology, a journal that has faced criticism over the years regarding industry influence and peer review standards. Concerns about conflicts of interest and transparency were raised as early as 2002.
Despite this, the journal remained part of the mainstream publishing ecosystem. Papers published within it continued to be treated as credible sources and were routinely cited.
How the Glyphosate Safety Narrative Was Shaped
By the time the Williams paper was published, the scientific and regulatory narrative around glyphosate had already shifted over time. Earlier concerns about carcinogenicity had been reassessed and, in some cases, downgraded.
The Williams paper didn’t create that shift, but it reinforced it by offering a consolidated, highly citable review. That made it particularly useful in regulatory and academic contexts.
How Glyphosate Research Was Managed and Influenced
The Monsanto Papers suggest that the company’s role extended beyond funding research. They describe coordinated efforts to shape how glyphosate-related information was presented and circulated, including the placement of favourable material.
In that context, a widely cited review paper becomes more than just a summary of evidence. It becomes part of the framework through which that evidence is interpreted.
Why the Glyphosate Study Wasn’t Challenged Sooner
Perhaps the most telling part of the timeline is what happened after 2017. The ghostwriting evidence was publicly known and widely discussed, yet no formal action was taken for years.
This points to a structural issue rather than a single failure. Different parts of the system operate with different responsibilities:
- Journals typically act when concerns are formally raised
- Scientists rely on published literature unless it is corrected
- Regulators reference existing evidence unless it is withdrawn
When responsibility is spread across multiple groups, it becomes easier for inaction to persist.
Why This Glyphosate Study Retraction Still Matters
It would be easy to treat this as a historical correction—a 25-year-old paper that has now been dealt with. But the impact of the delay suggests otherwise.
The Williams paper:
- Accumulated over 1,300 citations
- Continued to be cited after the 2017 revelations
- Appeared in regulatory documents without acknowledgment of the concerns
This means its influence did not end when questions were raised. It continued shaping scientific discussion and regulatory thinking for years afterwards.
What This Means for New Zealand’s Glyphosate Regulations
New Zealand’s regulatory framework, like many others, draws on international scientific literature when assessing agricultural chemicals and setting safety standards.
If widely cited studies within that literature are later found to have undisclosed authorship or incomplete data, it doesn’t automatically invalidate regulatory decisions. However, it does highlight an important point: the strength of any regulatory position depends on the reliability and transparency of the underlying evidence.
This is not about dismissing science. It is about understanding how that science is produced, reviewed, and maintained over time.
Are There Other Ghostwritten Glyphosate Studies?
The Williams paper is the first of the identified ghostwritten glyphosate papers to be formally retracted, but it is not the only one linked to the practices revealed in the Monsanto Papers.
Other publications have been identified and, in some cases, formally challenged. Those efforts have had mixed outcomes. Some have resulted in expressions of concern—an editorial warning that flags potential issues without removing the paper—while others remain in circulation.
This uneven response highlights a broader question within scientific publishing. Once a paper becomes widely cited and embedded in the literature, revisiting it is not always straightforward, even when concerns are publicly known.
What the Glyphosate Study Retraction Reveals
The retraction of Williams et al. (2000) is, on the surface, a correction. But at a deeper level, it offers a window into how scientific knowledge is built and maintained.
It shows that:
- Evidence can remain in circulation long after concerns are raised
- Widely cited papers can shape understanding for years, even when their origins are questioned
- Systems do not always move quickly, even when the information needed to act is already available
For readers, the takeaway is not that science cannot be trusted. It is that scientific understanding is shaped by processes—and those processes are not always as straightforward as they appear.
Which leads to a final question that sits slightly outside the paper itself:
If the evidence to justify retraction had been available for years, what else might still be sitting in plain sight—accepted, cited, and rarely revisited—not because it has been resolved, but because no one has yet taken responsibility for asking the next question?
Further reading on the Monsanto Papers and glyphosate research
The retraction of the Williams et al. paper does not exist in isolation. It sits within a much broader body of evidence that has emerged over the past decade, particularly through litigation and investigative reporting.
For readers wanting to better understand the context behind the Monsanto Papers, and how concerns about scientific integrity and industry influence came to light, the following articles provide a useful starting point.
The Monsanto Papers — Glyphosate’s Legal Battle
This article provides an overview of how internal Monsanto documents became public through court proceedings, revealing internal communications, research practices, and strategies used to defend glyphosate. It offers important context for understanding how issues such as ghostwriting came to be exposed.
Whitewash: Carey Gillam’s Monsanto Exposé
Based on investigative journalist Carey Gillam’s work, this piece explores the broader story behind glyphosate’s rise, including regulatory relationships, scientific disputes, and the role of industry influence in shaping public understanding.
Taken together, these articles help frame the retraction not as an isolated correction, but as part of a longer and more complex story about how scientific evidence is produced, interpreted, and, at times, contested.
Image Source & Attribution
The feature image on this page is a screenshot of the Williams, G.M., Kroes, R., & Munro, I.C. (2000). Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans. PDF, edited using Canva.com
